Besides Wall Street's top-and-bottom-line estimates for Humana (HUM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the ...

Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read ...

UnitedHealth Group Incorporated's Q2 reveals revenue growth but profit issues from rising costs and missteps. Click for my ...

Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a ...

Humana Inc. (NYSE:HUM) saw its share price drop to a 52-week low of $212.33, reflecting a steep 42.3% decline over the past ...

Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the morning session after the stock gained ...

Humana (NYSE:HUM) recently launched the inaugural Humana Cognitive Games™ to promote brain health among older adults, coinciding with their tenth year sponsoring the National Senior Games. This ...

We should also highlight that HUM has a P/B ratio of 1.64. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities.

This summary covers significant health news including FDA advisers rejecting Otsuka's PTSD treatment, Getinge exceeding ...

Shares of healthcare staffing company AMN Healthcare Services (NYSE:AMN) jumped 6% in the afternoon session after Truist Securities reiterated its 'Buy' rating on the company. The Wall Street firm ...

Valued at a market cap of $28 billion, Humana Inc. (HUM) is a leading U.S. health care plan provider offering medical and specialty insurance products. Operating through its Insurance and ...

UnitedHealth stock has plunged over 40% in 2025 and is approaching a key buy zone ahead of the Q2 2025 earnings.